• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CSL
Click for more information
0.45% $307.92

CSL LIMITED - Charts / Financials

Market Cap $149.0B  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

CSL Limited is an Australia-based biotechnology company. The Company’s areas of focus... CSL Limited is an Australia-based biotechnology company. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The Company operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others. More

refresh Created with Sketch. REFRESH
Last update - 15.59pm 27/08/2024 (20 minute delay) ?
Day
Open $308.98   Day High $310.00   Day Low $307.01
Daily Volume 258822
Bids   Sellers
Number Price Volume   Number Price Volume
1 $307.89 845   1 $307.94 307

Directors & Senior Management

Mr. Paul F. Mckenzie Chief Executive Officer, Managing Director, Executive Director
Ms. Joy Linton Chief Financial Officer
Ms. Roanne Parry Chief Human Resource Officer
Mr. Mark Hill Executive Vice President, Chief Digital Information Officer
Mr. Greg Boss Executive Vice President, Legal and CSL Group General Counsel
Mr. William Campbell Executive Vice President, Chief Commercial Officer
Mr. Ken Lim Executive Vice President, Chief Strategy Officer
Dr. William Mezzanotte Executive Vice President, Head Research & Development and Chief Medical Officer
Mr. Andy Schmeltz Executive Vice President - CSL Behring Business Unit
Mr. Herve Gisserot Senior Vice President, General Manager - CSL Vifor
Dr. Brian Anthony McNamee Non-Executive Independent Chairman of the Board
Ms. Samantha Louise Lewis Non-Executive Director
Dr. Megan Elizabeth Clark Independent Non-Executive Director
Ms. Carolyn Judith Hewson Independent Non-executive Director
Prof. Duncan John Maskell Independent Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
$307.92 		Change
-1.390(0.45%) 		Mkt cap ! $149.0B
Open High Low Value Volume
$308.98 $310.00 $307.01 $79.62M 258.8K

Buyers (Bids)

No. Vol. Price($)
1 845 $307.89
 

Sellers (Offers)

Price($) Vol. No.
$307.94 307 1
View Market Depth
Last trade - 16.10pm 27/08/2024 (20 minute delay) ?
Last
$307.04 		  Change
-1.390 ( 0.65 %)
Open High Low Volume
$309.08 $309.99 $307.04 110166
Last updated 15.59pm 27/08/2024 ?

Top Stories

Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings

A southward cluster of outcropping pegmatites on-site Chariot Corporation's (ASX:CC9) flagship Black Mountain hard rock lithium project has led management and geotechs to sign off on a promising future drilling target for the company as exploration on-site gathers pace.
Week 34 Wrap: HotCopper's top watched; Oz banks cut saver interest; Kamala’s 28% corporate tax; AI’s back This week’s biggest story (in my view) for the Australian economy actually started late last week. Quietly, CBA cut its term deposit interest rates, prompting ANZ and NAB to do the same on Monday of this week.
How flooding did Strategic Energy Resources a favour: Four holes down in 'redesigned' gold & copper campaign Strategic Energy Resources is 4 holes into a 40-hole RC drill campaign at its Achilles 1 copper-gold target in the Cobar Basin of NSW.
The Rising Tide: How institutional adoption is shaping the future of crypto This year's institutional demand for Bitcoin supports stability & credibility for the asset class. We look at what's happened since crypto ETFs were approved in the US & what that means for Australian investors.
Why are so many ASX explorers setting up shop in Saudi Arabia? + 8 stocks to watch You may have noticed in the last few years the name of a particular Kingdom popping up quite a lot on the ASX.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.